Back to News
Market Impact: 0.15
Hinge Health Reaches Analyst Target Price
Source: Nasdaq
Analyst InsightsMarket Technicals & Flows
Hinge Health shares recently traded at $112.00, slightly above the average analyst 12-month target price of $111.65. The article excerpt notes that analysts may respond when a stock reaches its target but is cut off before describing any specific response.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- ‘They are trying to intimidate us’: Indonesia’s Prabowo remains defiant in the face of an MSCI double downgrade
- US tech stocks tumble as investors fret over AI spending
- Asian shares wobble as tech rout boosts bonds, dents rate hike bets
- Asia stocks fall as AI rout batters S.Korea; Japan spooked by strong CPI
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
- Why is SK Hynix stock sliding today?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for Family Offices: A Stack by Decision Type
- Reading Conviction in the Tape: What Level 3 Order Book Data Really Tells Discretionary PMs